SCRS unveils Eagle Insights Dashboard to benchmark clinical trial site performance
The Society for Clinical Research Sites introduced a new data intelligence platform called the Eagle Insights Dashboard. The tool provides sponsors and contract research organizations with a composite score that reflects how sites perform across several key areas, including study start-up, business development, contract language, communication, patient population representation, and technology.
By aggregating these ratings, the dashboard enables users to spot engagement gaps early, compare performance with peers, and make data-driven decisions about investments and processes. SCRS says the insights can help strengthen site relationships and foster a more collaborative environment within the clinical trial community.
The platform will incorporate data from 2025 and 2026 by November, allowing trend analysis over time. A leading global biopharmaceutical company has already adopted the dashboard as part of its commitment to improve site collaborations.
This writeup was produced by pharmadog from original reporting by Fierce Biotech.
Original headline: “Advocacy organization launches data dashboard to better assess how clinical trial sites perform”
read at Fierce Biotech ↗
comments(0)
5-min edit window · permanent after that